<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04978389</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0462</org_study_id>
    <nct_id>NCT04978389</nct_id>
  </id_info>
  <brief_title>Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care</brief_title>
  <official_title>Inter-observer Reproductibility of Visual Estimation of Left Ventricular Ejection Fraction in Critical Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inter-observer reproductibility of visual estimation of left ventricular ejection fraction is&#xD;
      known to be good in cardiology but has not been studied in ICU. The goal of the study is to&#xD;
      determine if this reproductibility is good enough.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>reproductibility of LVEF in percentage</measure>
    <time_frame>day 1</time_frame>
    <description>reproductibility of LVEF in percentage</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Ventricular Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        practitioners working in intensive care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  practitioners working in intensive care.&#xD;
&#xD;
          -  age &gt; 18 years&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - Age under 18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kada KLOUCHE, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>UH Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kada KLOUCHE, MD PhD</last_name>
    <phone>+33467338441</phone>
    <email>k-klouche@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuel DEWAVRIN, MD</last_name>
    <phone>630879376</phone>
    <phone_ext>33</phone_ext>
    <email>emmanuel.dewavrin@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kada KLOUCHE, MD PhD</last_name>
      <phone>467338441</phone>
      <phone_ext>33</phone_ext>
      <email>k-klouche@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Emmanuel DEWAVRIN</last_name>
      <phone>630879376</phone>
      <phone_ext>33</phone_ext>
      <email>emmanuel.dewavrin@chu-montpellier.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

